.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Harvard Business School
McKinsey
Covington
Medtronic
Express Scripts
McKesson
Chinese Patent Office
Cipla
US Army

Generated: July 28, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Method for treatment or prevention of obesity
Abstract:A method is disclosed for treating obese mammals or preventing obesity from occurring in mammals. This method involves administering to the mammal an effective amount of growth hormone in combination with an effective amount of IGF-I. Preferably, the growth hormone is given so as to have a maintained, continual therapeutically effective presence in the blood, such as by continuous infusion or frequent injections, or by use of a long-acting formulation.
Inventor(s): Clark; Ross G. (Pacifica, CA)
Assignee: Genentech, Inc. (South San Francisco, CA)
Filing Date:Nov 19, 1993
Application Number:08/150,090
Claims:1. A method for reducing total body fat mass in an obese mammal comprising administering to the mammal an effective amount of IGF-I and growth hormone.

2. The method of claim 1 wherein the mammal is a human.

3. The method of claim 2 wherein the human has Type II diabetes and the need of the human for insulin is decreased upon the administration of growth hormone and IGF-I.

4. The method of claim 2 wherein the growth hormone is human native-sequence, mature growth hormone.

5. The method of claim 2 wherein the IGF-I is human native-sequence, mature IGF-I.

6. The method of claim 4 wherein the IGF-I is human native-sequence, mature IGF-I.

7. The method of claim 1 wherein the administration of IGF-I is be continuous infusion.

8. The method of claim 1 wherein the IGF-I is in a sustained- release formulation.

9. The method of claim 1 wherein the administration of growth hormone is by injection.

10. The method of claim 1 wherein the growth hormone is administered such that its therapeutically effective concentration is maintained continuously in the blood of the mammal for the duration of the period of its administration.

11. The method of claim 10 wherein the administration of growth hormone is by continuous infusion.

12. The method of claim 10 wherein the growth hormone is in a sustained-release formulation.

13. The method of claim 10 wherein the growth hormone is covalently conjugated via up to ten amino acid residues to a water-soluble polymer selected from the group consisting of polyethylene glycol homopolymers and polyoxyethylene polyols.

14. The method of claim 10 wherein the growth hormone is covalently conjugated to polyethylene glycol via 2 to 8 lysine residues on the growth hormone.

15. The method of claim 1 wherein the growth hormone is administered with a growth hormone binding protein.

16. The method of claim 1 wherein the effective amount of growth hormone is at least 0.01 mg/kg/day.

17. the method of claim 1 wherein the effective amount of IGF-I is at least 0.01 mg/kg/day.

18. The method of claim 1 wherein the growth hormone and IGF-I are administered separately.

19. The method of claim 1 wherein the growth hormone and IGF-I are administered as a single formulation.

20. The method of claim 1 wherein the IGF-I is administered with an IGF binding protein.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Cerilliant
Baxter
Teva
Julphar
US Army
Medtronic
Deloitte
Healthtrust
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot